Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery

Clinical trial NCT05169866 · UNKNOWN

Trial details

NCT number: NCT05169866
Sponsor: Beijing Anzhen Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

New Onset Atrial Fibrillation Complications; Cardiac, Postoperative

Start date: 2022-05-29
Primary completion: 2025-05-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.